BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 34817551)

  • 1. DCIR and its ligand asialo-biantennary N-glycan regulate DC function and osteoclastogenesis.
    Kaifu T; Yabe R; Maruhashi T; Chung SH; Tateno H; Fujikado N; Hirabayashi J; Iwakura Y
    J Exp Med; 2021 Dec; 218(12):. PubMed ID: 34817551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ligand binding and signaling of dendritic cell immunoreceptor (DCIR) is modulated by the glycosylation of the carbohydrate recognition domain.
    Bloem K; Vuist IM; van der Plas AJ; Knippels LM; Garssen J; García-Vallejo JJ; van Vliet SJ; van Kooyk Y
    PLoS One; 2013; 8(6):e66266. PubMed ID: 23776650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DCIR interacts with ligands from both endogenous and pathogenic origin.
    Bloem K; Vuist IM; van den Berk M; Klaver EJ; van Die I; Knippels LM; Garssen J; García-Vallejo JJ; van Vliet SJ; van Kooyk Y
    Immunol Lett; 2014; 158(1-2):33-41. PubMed ID: 24239607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exacerbation of experimental autoimmune encephalomyelitis in mice deficient for DCIR, an inhibitory C-type lectin receptor.
    Seno A; Maruhashi T; Kaifu T; Yabe R; Fujikado N; Ma G; Ikarashi T; Kakuta S; Iwakura Y
    Exp Anim; 2015; 64(2):109-19. PubMed ID: 26176030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DCIR suppresses osteoclastic proliferation and resorption by downregulating M-CSF and RANKL signaling.
    Kaifu T; Maruhashi T; Chung SH; Shimizu K; Nakamura A; Iwakura Y
    Front Immunol; 2023; 14():1159058. PubMed ID: 37266426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dcir deficiency causes development of autoimmune diseases in mice due to excess expansion of dendritic cells.
    Fujikado N; Saijo S; Yonezawa T; Shimamori K; Ishii A; Sugai S; Kotaki H; Sudo K; Nose M; Iwakura Y
    Nat Med; 2008 Feb; 14(2):176-80. PubMed ID: 18204462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-priming CD8+ T cells by targeting antigens to human dendritic cells through DCIR.
    Klechevsky E; Flamar AL; Cao Y; Blanck JP; Liu M; O'Bar A; Agouna-Deciat O; Klucar P; Thompson-Snipes L; Zurawski S; Reiter Y; Palucka AK; Zurawski G; Banchereau J
    Blood; 2010 Sep; 116(10):1685-97. PubMed ID: 20530286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signaling and immune regulatory role of the dendritic cell immunoreceptor (DCIR) family lectins: DCIR, DCAR, dectin-2 and BDCA-2.
    Kanazawa N; Tashiro K; Miyachi Y
    Immunobiology; 2004; 209(1-2):179-90. PubMed ID: 15481152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. APCs express DCIR, a novel C-type lectin surface receptor containing an immunoreceptor tyrosine-based inhibitory motif.
    Bates EE; Fournier N; Garcia E; Valladeau J; Durand I; Pin JJ; Zurawski SM; Patel S; Abrams JS; Lebecque S; Garrone P; Saeland S
    J Immunol; 1999 Aug; 163(4):1973-83. PubMed ID: 10438934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DC-SIGN plays a stronger role than DCIR in mediating HIV-1 capture and transfer.
    Jin W; Li C; Du T; Hu K; Huang X; Hu Q
    Virology; 2014 Jun; 458-459():83-92. PubMed ID: 24928041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DCIR is endocytosed into human dendritic cells and inhibits TLR8-mediated cytokine production.
    Meyer-Wentrup F; Cambi A; Joosten B; Looman MW; de Vries IJ; Figdor CG; Adema GJ
    J Leukoc Biol; 2009 Mar; 85(3):518-25. PubMed ID: 19028959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of transcripts for the autoimmunity-related human dendritic cell immunoreceptor.
    Ronninger M; Eklöw C; Lorentzen JC; Klareskog L; Padyukov L
    Genes Immun; 2008 Jul; 9(5):412-8. PubMed ID: 18480830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DCIR-mediated enhancement of HIV-1 infection requires the ITIM-associated signal transduction pathway.
    Lambert AA; Barabé F; Gilbert C; Tremblay MJ
    Blood; 2011 Jun; 117(24):6589-99. PubMed ID: 21536857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting DCIR on human plasmacytoid dendritic cells results in antigen presentation and inhibits IFN-alpha production.
    Meyer-Wentrup F; Benitez-Ribas D; Tacken PJ; Punt CJ; Figdor CG; de Vries IJ; Adema GJ
    Blood; 2008 Apr; 111(8):4245-53. PubMed ID: 18258799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dendritic cell immunoreceptor: a novel receptor for intravenous immunoglobulin mediates induction of regulatory T cells.
    Massoud AH; Yona M; Xue D; Chouiali F; Alturaihi H; Ablona A; Mourad W; Piccirillo CA; Mazer BD
    J Allergy Clin Immunol; 2014 Mar; 133(3):853-63.e5. PubMed ID: 24210883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 induces DCIR expression in CD4+ T cells.
    Lambert AA; Imbeault M; Gilbert C; Tremblay MJ
    PLoS Pathog; 2010 Nov; 6(11):e1001188. PubMed ID: 21085612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DCIR acts as an inhibitory receptor depending on its immunoreceptor tyrosine-based inhibitory motif.
    Kanazawa N; Okazaki T; Nishimura H; Tashiro K; Inaba K; Miyachi Y
    J Invest Dermatol; 2002 Feb; 118(2):261-6. PubMed ID: 11841542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-type lectin receptor DCIR contributes to hippocampal injury in acute neurotropic virus infection.
    Stoff M; Ebbecke T; Ciurkiewicz M; Pavasutthipaisit S; Mayer-Lambertz S; Störk T; Pavelko KD; Baumgärtner W; Jung K; Lepenies B; Beineke A
    Sci Rep; 2021 Dec; 11(1):23819. PubMed ID: 34893671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular distribution of the C-type II lectin dendritic cell immunoreceptor (DCIR) and its expression in the rheumatic joint: identification of a subpopulation of DCIR+ T cells.
    Eklöw C; Makrygiannakis D; Bäckdahl L; Padyukov L; Ulfgren AK; Lorentzen JC; Malmström V
    Ann Rheum Dis; 2008 Dec; 67(12):1742-9. PubMed ID: 18250113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dendritic cell immunoreceptors: C-type lectin receptors for pattern-recognition and signaling on antigen-presenting cells.
    Kanazawa N
    J Dermatol Sci; 2007 Feb; 45(2):77-86. PubMed ID: 17046204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.